|
US2920999A
(en)
|
1957-06-07 |
1960-01-12 |
Pfizer & Co C |
21-nitrogen derivatives of corticosteroids
|
|
GB889766A
(en)
|
1958-03-04 |
1962-02-21 |
Olin Mathieson |
Improvements in steroids and the synthesis thereof
|
|
DE1165595B
(de)
|
1958-03-04 |
1964-03-19 |
Olin Mathieson |
Verfahren zur Herstellung von Triamcinolonacetonid-21-hemisuccinat und dessen Salzen
|
|
US3197469A
(en)
|
1958-08-06 |
1965-07-27 |
Pharmaceutical Res Products In |
16, 17-acetals and ketals of 6-halo-16, 17-dihydroxy steroids of the pregnane seriesand intermediates therefor
|
|
US3007923A
(en)
|
1959-01-22 |
1961-11-07 |
Lab Francais Chimiotherapie |
Process for the fluorination of 9beta, 11beta-epoxy and 5alpha, 6alpha-epoxy steroids
|
|
GB898291A
(en)
|
1959-03-18 |
1962-06-06 |
Upjohn Co |
Improvements in or relating to steroids and the manufacture thereof
|
|
US3033874A
(en)
|
1960-05-11 |
1962-05-08 |
Pfizer & Co C |
17beta-propenoyl steroids and process for preparing same
|
|
US3033873A
(en)
|
1960-05-11 |
1962-05-08 |
Pfizer & Co C |
21-aminomethyl-pregnenes
|
|
US3020275A
(en)
|
1960-06-07 |
1962-02-06 |
American Cyanamid Co |
21-nitrogen substituted steroids of the pregnane series and methods of preparing the same
|
|
DE1169444B
(de)
|
1961-02-22 |
1964-05-06 |
Schering Ag |
Verfahren zur Herstellung von ?-16ª-Methylsteroiden
|
|
US3047468A
(en)
|
1961-06-06 |
1962-07-31 |
American Cyanamid Co |
Method of preparing delta1, 4-3-keto steroids of the pregnane series
|
|
US3383394A
(en)
|
1965-08-30 |
1968-05-14 |
Schering Corp |
Novel 17-acylating process and products thereof
|
|
US3798216A
(en)
|
1969-03-07 |
1974-03-19 |
Fabrication Des Antibiotique S |
9-fluoro-11beta,21-dihydroxy-16alpha,17-(2-propenylidenedioxy)-pregna-1,4-diene-3,20-dione and derivatives thereof
|
|
DE2047105C3
(de)
|
1970-09-18 |
1979-02-15 |
Schering Ag, 1000 Berlin Und 4619 Bergkamen |
17-Chlorsteroide und Verfahren zu ihrer Herstellung
|
|
IT1057859B
(it)
|
1972-04-28 |
1982-03-30 |
Sigma Tao Ind Farmaceutiche Sp |
Perivato del triamoinolone
|
|
SE378109B
(https=)
|
1972-05-19 |
1975-08-18 |
Bofors Ab |
|
|
SE378110B
(https=)
|
1972-05-19 |
1975-08-18 |
Bofors Ab |
|
|
US4076737A
(en)
|
1975-02-20 |
1978-02-28 |
Ciba-Geigy Corporation |
Aldehydes of the pregnane series and derivatives thereof
|
|
IL73337A
(en)
|
1984-10-28 |
1988-09-30 |
Yissum Res Dev Co |
Antitumor steroid-platinum complexes and method for the preparation thereof
|
|
SE8604059D0
(sv)
|
1986-09-25 |
1986-09-25 |
Astra Pharma Prod |
A method of controlling the epimeric distribution in the preparation of 16,17-acetals of pregnane derivatives
|
|
IL85035A0
(en)
|
1987-01-08 |
1988-06-30 |
Int Genetic Eng |
Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same
|
|
US5208020A
(en)
|
1989-10-25 |
1993-05-04 |
Immunogen Inc. |
Cytotoxic agents comprising maytansinoids and their therapeutic use
|
|
US5116829A
(en)
|
1990-04-23 |
1992-05-26 |
Kao Corporation |
Steroid compounds
|
|
US5183815A
(en)
|
1991-01-22 |
1993-02-02 |
Merck & Co., Inc. |
Bone acting agents
|
|
EP1400536A1
(en)
|
1991-06-14 |
2004-03-24 |
Genentech Inc. |
Method for making humanized antibodies
|
|
CA2152374A1
(en)
|
1993-01-08 |
1994-07-21 |
Ralph Lennart Brattsand |
Novel colon- or ileum-specific steroid derivatives
|
|
DE4311987A1
(de)
|
1993-04-07 |
1994-10-13 |
Schering Ag |
Neue Glucocorticoide
|
|
US5714586A
(en)
|
1995-06-07 |
1998-02-03 |
American Cyanamid Company |
Methods for the preparation of monomeric calicheamicin derivative/carrier conjugates
|
|
US5824669A
(en)
|
1996-03-22 |
1998-10-20 |
Nitromed, Inc. |
Nitrosated and nitrosylated compounds and compositions and their use for treating respiratory disorders
|
|
US5837698A
(en)
|
1996-05-02 |
1998-11-17 |
G. D. Searle & Co. |
Steroid nitrite and nitrate ester derivatives useful as anti-inflammatory drugs
|
|
WO2000049993A2
(en)
|
1999-02-24 |
2000-08-31 |
Nitromed, Inc. |
Nitrosated and nitrosylated steroids for the treatment of cardiovascular diseases and disorders
|
|
US6596541B2
(en)
|
2000-10-31 |
2003-07-22 |
Regeneron Pharmaceuticals, Inc. |
Methods of modifying eukaryotic cells
|
|
US20070258987A1
(en)
|
2000-11-28 |
2007-11-08 |
Seattle Genetics, Inc. |
Recombinant Anti-Cd30 Antibodies and Uses Thereof
|
|
SE0101220D0
(sv)
|
2001-04-04 |
2001-04-04 |
Astrazeneca Ab |
New use
|
|
US6908934B2
(en)
|
2001-06-11 |
2005-06-21 |
Merck & Co., Inc. |
Therapeutic compounds for treating dyslipidemic conditions
|
|
ITMI20020148A1
(it)
|
2002-01-29 |
2003-07-29 |
Nicox Sa |
Nuovi corticosteroidi
|
|
US20050009798A1
(en)
|
2002-02-20 |
2005-01-13 |
Sepracor Inc. |
Carbonate and carbamate modified forms of glucocorticoids in combination with B2 adrenergic agonists
|
|
US7190468B2
(en)
|
2002-07-17 |
2007-03-13 |
Hewlett-Packard Development Company, L.P. |
Background document rendering system and method
|
|
SI1545613T1
(sl)
|
2002-07-31 |
2011-11-30 |
Seattle Genetics Inc |
Avristatinski konjugati in njihova uporaba za zdravljenje raka avtoimunske bolezni ali infekcijskebolezni
|
|
US20040157810A1
(en)
|
2002-08-23 |
2004-08-12 |
Teicher Martin H. |
Corticosteroid conjugates and uses thereof
|
|
BRPI0314042B8
(pt)
|
2002-09-06 |
2021-05-25 |
Calando Pharmaceuticals Inc |
polímeros à base de ciclodextrina para o fornecimento de agentes terapêuticos ligados a eles por covalência
|
|
CN1414008A
(zh)
|
2002-10-17 |
2003-04-30 |
南开大学 |
含氮甾体化合物及其制备方法
|
|
US7015349B2
(en)
|
2003-03-26 |
2006-03-21 |
The Gillette Company |
Reduction of hair growth
|
|
US7498298B2
(en)
|
2003-11-06 |
2009-03-03 |
Seattle Genetics, Inc. |
Monomethylvaline compounds capable of conjugation to ligands
|
|
WO2005063777A1
(en)
|
2003-12-23 |
2005-07-14 |
Corus Pharma |
Benzylphosphate and substituted benzylphosphate prodrugs for the treatment of pulmonary inflammation
|
|
WO2005079523A2
(en)
*
|
2004-02-18 |
2005-09-01 |
University Of Georgia Research Foundation, Inc. |
Novel teleost derived antimicrobal polypeptides
|
|
EP1718667B1
(en)
|
2004-02-23 |
2013-01-09 |
Genentech, Inc. |
Heterocyclic self-immolative linkers and conjugates
|
|
US20050192257A1
(en)
|
2004-02-26 |
2005-09-01 |
Peyman Gholam A. |
Predictors for patients at risk for glaucoma from steroid therapy
|
|
AR048098A1
(es)
|
2004-03-15 |
2006-03-29 |
Wyeth Corp |
Conjugados de caliqueamicina
|
|
KR20120064120A
(ko)
|
2004-06-01 |
2012-06-18 |
제넨테크, 인크. |
항체 약물 접합체 및 방법
|
|
EP1602931A1
(en)
|
2004-06-03 |
2005-12-07 |
Universiteit Leiden |
SR-A antagonists
|
|
US7541330B2
(en)
|
2004-06-15 |
2009-06-02 |
Kosan Biosciences Incorporated |
Conjugates with reduced adverse systemic effects
|
|
EP1625854B1
(en)
|
2004-08-09 |
2008-10-15 |
Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts |
Albumin conjugates containing a glucuronic linker
|
|
TW200616604A
(en)
|
2004-08-26 |
2006-06-01 |
Nicholas Piramal India Ltd |
Nitric oxide releasing prodrugs containing bio-cleavable linker
|
|
EP1817341A2
(en)
|
2004-11-29 |
2007-08-15 |
Seattle Genetics, Inc. |
Engineered antibodies and immunoconjugates
|
|
WO2006135371A1
(en)
|
2005-06-09 |
2006-12-21 |
Kosan Biosciences Incorporated |
Conjugates with reduced adverse systemic effects
|
|
EP1893220A4
(en)
|
2005-06-14 |
2011-06-15 |
Gilead Sciences Inc |
SUBSTITUTED PHENYLPHOSPHATES AS MUTUAL PROMO PRODUCTS CONSISTING OF STEROIDS AND BETA-AGONISTS FOR THE TREATMENT OF PULMONARY INFLAMMATION AND BRONCHOCONSTRICTION
|
|
US7750116B1
(en)
|
2006-02-18 |
2010-07-06 |
Seattle Genetics, Inc. |
Antibody drug conjugate metabolites
|
|
ES2398076T3
(es)
|
2006-06-02 |
2013-03-13 |
Regeneron Pharmaceuticals, Inc. |
Anticuerpos de alta afinidad contra el receptor de IL-6 humano
|
|
US8354508B2
(en)
*
|
2006-07-21 |
2013-01-15 |
Diadexus, Inc. |
PRO115 antibody compositions and methods of use
|
|
BRPI0807078A2
(pt)
|
2007-02-05 |
2014-04-08 |
Nicox Sa |
Composto, e, formulação farmacêutica
|
|
WO2008122039A2
(en)
|
2007-04-02 |
2008-10-09 |
The Government Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Selenocysteine mediated hybrid antibody molecules
|
|
JP2010528285A
(ja)
|
2007-05-23 |
2010-08-19 |
ベンタナ・メデイカル・システムズ・インコーポレーテツド |
免疫組織化学およびｉｎｓｉｔｕハイブリダーゼーションのためのポリマー担体
|
|
BRPI0812970A2
(pt)
|
2007-06-25 |
2019-09-24 |
Endocyte Inc |
conjugados contendo espaçadores hidrofílicos
|
|
CA2692021A1
(en)
|
2007-06-28 |
2008-12-31 |
Capsutech Ltd |
Targeting conjugates comprising active agents encapsulated in cyclodextrin-containing polymers
|
|
CN101397328A
(zh)
|
2007-09-27 |
2009-04-01 |
天津药业研究院有限公司 |
一氧化氮供体型糖皮质激素
|
|
JP5484339B2
(ja)
|
2007-10-05 |
2014-05-07 |
ウェイン ステート ユニバーシティー |
合成物の持続的な放出のためのデンドリマー
|
|
EP2235035A2
(en)
|
2007-12-21 |
2010-10-06 |
Schering Corporation |
C-21 thioethers as glucocorticoid receptor agonists
|
|
CA2710149A1
(en)
|
2007-12-21 |
2009-07-09 |
John C. Anthes |
C20-c21 substituted glucocorticoid receptor agonists
|
|
EP2276506A4
(en)
|
2008-04-30 |
2014-05-07 |
Immunogen Inc |
EFFICIENT CONJUGATES AND HYDROPHILIC BINDER
|
|
US20090318396A1
(en)
|
2008-06-10 |
2009-12-24 |
Gilead Sciences, Inc. |
Corticosteroid linked beta-agonist compounds for use in therapy
|
|
EP2374481B1
(en)
|
2008-07-21 |
2015-11-04 |
Polytherics Limited |
Novel reagents and method for conjugating biological molecules
|
|
WO2010010119A1
(en)
*
|
2008-07-22 |
2010-01-28 |
Ablynx Nv |
Amino acid sequences directed against multitarget scavenger receptors and polypeptides
|
|
AU2010221972B2
(en)
|
2009-03-09 |
2012-07-05 |
Mikasa Seiyaku Co., Ltd. |
Steroid compound
|
|
WO2010126953A1
(en)
|
2009-04-29 |
2010-11-04 |
Gilead Sciences, Inc. |
Corticosteroid linked beta-agonist compounds for use in therapy
|
|
WO2010132743A1
(en)
|
2009-05-15 |
2010-11-18 |
Gilead Sciences, Inc. |
Corticosteroid beta-agonist compounds for use in therapy
|
|
JP5954789B2
(ja)
|
2009-08-10 |
2016-07-20 |
ユーシーエル ビジネス パブリック リミテッド カンパニー |
機能的分子の可逆的共有結合
|
|
WO2011020107A2
(en)
|
2009-08-14 |
2011-02-17 |
Georgetown University |
Compositions and methods for detection and treatment of breast cancer
|
|
GB0917044D0
(en)
|
2009-09-29 |
2009-11-18 |
Cytoguide As |
Agents, uses and methods
|
|
GB0917054D0
(en)
|
2009-09-29 |
2009-11-11 |
Cytoguide As |
Agents, uses and methods
|
|
WO2011081937A1
(en)
|
2009-12-15 |
2011-07-07 |
Gilead Sciences, Inc. |
Corticosteroid-beta-agonist-muscarinic antagonist compounds for use in therapy
|
|
US20110178287A1
(en)
|
2010-01-19 |
2011-07-21 |
Cerulean Pharma Inc. |
Cyclodextrin-based polymers for therapeutic delivery
|
|
WO2011103389A1
(en)
*
|
2010-02-19 |
2011-08-25 |
Cornell University |
Method to treat autoimmune demyelinating diseases and other autoimmune or inflammatory diseases
|
|
DK2528625T3
(da)
|
2010-04-15 |
2013-10-14 |
Spirogen Sarl |
Pyrrolobenzodiazepiner og konjugater deraf
|
|
US20130244905A1
(en)
|
2010-07-06 |
2013-09-19 |
Ed Grabczyk |
Reporter for RNA Polymerase II Termination
|
|
BR112013001634A2
(pt)
*
|
2010-07-23 |
2016-05-24 |
Takeda Pharmaceutical |
composto ou sal, medicamento, métodos para a profilaxia ou tratamento da arteriosclerose, da diabete ou obesidade em um mamífero, e, uso do composto ou sal
|
|
SG10201912639SA
(en)
|
2010-08-02 |
2020-02-27 |
Regeneron Pharma |
Mice that make binding proteins comprising vl domains
|
|
MY162780A
(en)
|
2010-09-01 |
2017-07-14 |
Bayer Ip Gmbh |
N-(Tetrazol-5-yl)- and N-(triazol-5-yl)arylcarboxamides and use thereof as herbicides
|
|
CN105399831A
(zh)
|
2010-10-29 |
2016-03-16 |
伊缪诺金公司 |
非拮抗性egfr结合分子及其免疫偶联物
|
|
WO2012145632A1
(en)
|
2011-04-21 |
2012-10-26 |
Cerulean Pharma Inc. |
Cyclodextrin-based polymers for therapeutic delivery
|
|
KR20140037105A
(ko)
|
2011-05-27 |
2014-03-26 |
암브룩스, 인코포레이티드 |
비-천연 아미노산 연결된 돌라스타틴 유도체를 함유하는 조성물, 이를 수반하는 방법, 및 용도
|
|
US8815226B2
(en)
|
2011-06-10 |
2014-08-26 |
Mersana Therapeutics, Inc. |
Protein-polymer-drug conjugates
|
|
WO2013055993A1
(en)
|
2011-10-14 |
2013-04-18 |
Seattle Genetics, Inc. |
Pyrrolobenzodiazepines and targeted conjugates
|
|
CA2850096C
(en)
|
2011-10-14 |
2018-07-03 |
Spirogen Sarl |
Synthesis method and intermediates useful in the preparation of pyrrolobenzodiazepines
|
|
ES2945932T3
(es)
|
2011-10-14 |
2023-07-10 |
Seagen Inc |
Pirrolobenzodiazepinas y conjugados dirigidos
|
|
CA2850103C
(en)
|
2011-10-14 |
2019-09-10 |
Spirogen Sarl |
Pyrrolobenzodiazepines
|
|
WO2013068874A1
(en)
|
2011-11-11 |
2013-05-16 |
Pfizer Inc. |
Antibody-drug conjugates
|
|
CN104244718A
(zh)
|
2011-12-05 |
2014-12-24 |
伊格尼卡生物治疗公司 |
抗体-药物缀合物以及相关化合物、组合物和方法
|
|
GB201122325D0
(en)
|
2011-12-23 |
2012-02-01 |
Cytoguide As |
Novel formulations
|
|
MX361875B
(es)
|
2012-03-14 |
2018-12-18 |
Regeneron Pharma |
Moléculas de unión de antígeno multiespecifícas y usos de las mismas.
|
|
JP2015521602A
(ja)
|
2012-06-14 |
2015-07-30 |
アンブルックス, インコーポレイテッドAmbrx, Inc. |
核受容体リガンドポリペプチドに対して複合化されている抗ｐｓｍａ抗体
|
|
CA2885169C
(en)
|
2012-10-11 |
2021-06-22 |
Ascendis Pharma A/S |
Diagnosis, prevention and treatment of diseases of the joint
|
|
EP2908818A4
(en)
|
2012-10-16 |
2016-07-13 |
Endocyte Inc |
CONJUGATES OF DRUG DELIVERY CONTAINING ARTIFICIAL AMINO ACIDS AND METHODS OF USE
|
|
FI2911699T4
(fi)
|
2012-10-23 |
2025-12-09 |
Synaffix Bv |
Muokattu vasta-aine, vasta-ainekonjugaatti ja menetelmä niiden valmistamiseksi
|
|
US9376420B2
(en)
|
2012-10-25 |
2016-06-28 |
Yuhan Corporation |
4,5-dihydro-1H-pyrazole derivative or salts thereof, and pharmaceutical composition comprising same
|
|
CN105102480B
(zh)
|
2012-12-24 |
2019-04-16 |
艾伯维公司 |
催乳素受体结合蛋白及其用途
|
|
EA201591710A1
(ru)
|
2013-03-13 |
2016-03-31 |
Сиэтл Дженетикс, Инк. |
Композиции, содержащие циклодекстрин и конъюгат антитело-лекарственное средство
|
|
WO2014176284A1
(en)
|
2013-04-22 |
2014-10-30 |
Avelas Biosciences, Inc. |
Selective drug delivery compositions and methods of use
|
|
US11229711B2
(en)
|
2013-06-06 |
2022-01-25 |
Magenta Therapeutics, Inc. |
Linkers for antibody-drug conjugates and related compounds, compositions, and methods of use
|
|
JP6744212B2
(ja)
|
2013-06-21 |
2020-08-19 |
イナート・ファルマ・ソシエテ・アノニムＩｎｎａｔｅ Ｐｈａｒｍａ Ｐｈａｒｍａ Ｓ．Ａ． |
ポリペプチドの酵素的結合
|
|
EP3020417A4
(en)
|
2013-07-10 |
2017-01-18 |
Seikagaku Corporation |
Pharmaceutical composition for respiratory administration
|
|
TWI641620B
(zh)
|
2013-08-21 |
2018-11-21 |
再生元醫藥公司 |
抗－ｐｒｌｒ抗體及其用途
|
|
ES2826398T3
(es)
|
2013-10-15 |
2021-05-18 |
Seagen Inc |
Enlazadores-fármacos pegilados para una mejor farmacocinética de los conjugados ligando-fármaco
|
|
CN103694375B
(zh)
|
2013-12-13 |
2016-10-05 |
北京大学 |
一种三萜-环糊精共价化合物及其制备方法和用途
|
|
US10485811B2
(en)
|
2014-01-24 |
2019-11-26 |
Centre National De La Recherche Scientifique |
Orally available compounds, a process for preparing the same and their uses as anti-adhesive drugs for treating E. coli induced inflammatory bowel diseases such as crohn's disease
|
|
EP3125943B1
(en)
*
|
2014-04-04 |
2026-04-22 |
Merck Sharp & Dohme LLC |
Phosphate based linkers for intracellular delivery of drug conjugates
|
|
KR102399277B1
(ko)
|
2014-04-10 |
2022-05-18 |
다이이찌 산쿄 가부시키가이샤 |
항her3 항체-약물 콘주게이트
|
|
CA2950155C
(en)
|
2014-06-02 |
2021-11-23 |
Regeneron Pharmaceuticals, Inc. |
Biologically active molecule conjugates, reagents and methods of manufacture, and therapeutic uses
|
|
FI3166638T3
(fi)
|
2014-06-13 |
2025-09-17 |
Glykos Finland Oy |
Hyötykuorma-polymeeri-proteiini konjugaatteja
|
|
HK1243931A1
(zh)
|
2014-12-03 |
2018-07-27 |
F. Hoffmann-La Roche Ag |
抗金黄色葡萄球菌抗体利福霉素缀合物及其用途
|
|
BR112017011478A2
(pt)
|
2014-12-03 |
2018-02-27 |
Genentech, Inc. |
composto de conjugado anticorpo-antibiótico, conjugado anticorpo-antibiótico, composição farmacêutica, métodos de tratamento de uma infecção bacteriana e para exterminar staph aureus, processo para a preparação do composto, kit e intermediário antibiótico-ligante
|
|
BR112017012342A2
(pt)
|
2014-12-09 |
2018-02-27 |
Abbvie Inc |
compostos inibitórios de bcl-xl e conjugados de anticorpo-fármaco incluindo os mesmos
|
|
KR20170093943A
(ko)
|
2014-12-09 |
2017-08-16 |
애브비 인코포레이티드 |
낮은 세포 투과성을 갖는 bcl xl 억제 화합물 및 이를 포함하는 항체 약물 접합체
|
|
WO2016120891A1
(en)
|
2015-01-30 |
2016-08-04 |
Coral Drugs Pvt. Ltd. |
Novel process for preparation of glucocorticoid steroids
|
|
EP3253212A4
(en)
|
2015-02-06 |
2018-09-19 |
Sorrento Therapeutics, Inc. |
Antibody drug conjugates
|
|
MY189159A
(en)
*
|
2015-07-06 |
2022-01-29 |
Regeneron Pharma |
Multispecific antigen-binding molecules and uses thereof
|
|
WO2017006279A1
(en)
|
2015-07-08 |
2017-01-12 |
Aten Porus Lifesciences |
Cyclodextrin-polymer complexes and compostions and methods of making and using the same
|
|
JP6823067B2
(ja)
|
2015-09-10 |
2021-01-27 |
タンボ・インコーポレイテッド |
生体直交型組成物
|
|
WO2017062271A2
(en)
|
2015-10-06 |
2017-04-13 |
Merck Sharp & Dohme Corp. |
Antibody drug conjugate for anti-inflammatory applications
|
|
EP3407916B1
(en)
|
2016-01-29 |
2023-12-20 |
Merck Sharp & Dohme LLC |
Phosphonate linkers and their use to facilitate cellular retention of compounds
|
|
WO2017147542A2
(en)
|
2016-02-26 |
2017-08-31 |
Regeneron Pharmaceuticals, Inc. |
Optimized transglutaminase site-specific antibody conjugation
|
|
KR20180134351A
(ko)
|
2016-03-25 |
2018-12-18 |
시애틀 지네틱스, 인크. |
페길화된 약물-링커 및 그의 중간체의 제조를 위한 공정
|
|
GB201608936D0
(en)
*
|
2016-05-20 |
2016-07-06 |
Polytherics Ltd |
Novel conjugates and novel conjugating reagents
|
|
MY194619A
(en)
|
2016-06-02 |
2022-12-07 |
Abbvie Inc |
Glucocorticoid receptor agonist and immunoconjugates thereof
|
|
BR112018075644A2
(pt)
|
2016-06-08 |
2019-04-09 |
Abbvie Inc. |
anticorpos anti-cd98 e conjugados de anticorpo e fármaco
|
|
MX2019003325A
(es)
|
2016-09-23 |
2019-08-05 |
Regeneron Pharma |
Anticuerpos anti-steap2, conjugados anticuerpo-farmaco, y moleculas de fijacion al antigeno biespecificas que se fijan a steap2 y cd3, y usos de estos.
|
|
KR20250114431A
(ko)
|
2016-11-08 |
2025-07-29 |
리제너론 파마슈티칼스 인코포레이티드 |
스테로이드 및 이의 단백질-접합체
|
|
KR20250171447A
(ko)
|
2017-02-28 |
2025-12-08 |
이뮤노젠 아이엔씨 |
자기희생적 펩티드 링커 및 이들의 접합체를 갖는 메이탄시노이드 유도체
|
|
WO2018213082A1
(en)
|
2017-05-18 |
2018-11-22 |
Regeneron Pharmaceuticals, Inc. |
Bis-octahydrophenanthrene carboxamides and protein conjugates thereof
|
|
KR20250008984A
(ko)
*
|
2017-05-18 |
2025-01-16 |
리제너론 파마슈티칼스 인코포레이티드 |
사이클로덱스트린 단백질 약물 접합체
|
|
CN118652192A
(zh)
|
2017-05-24 |
2024-09-17 |
德克萨斯州大学系统董事会 |
用于抗体药物缀合物的接头
|
|
CN109106951A
(zh)
|
2017-08-18 |
2019-01-01 |
四川百利药业有限责任公司 |
一种喜树碱-抗体偶联物
|
|
CN108853514B
(zh)
|
2017-08-18 |
2022-07-22 |
四川百利药业有限责任公司 |
具有两种不同药物的抗体药物偶联物
|
|
MX2020004691A
(es)
|
2017-11-07 |
2020-08-20 |
Regeneron Pharma |
Enlazadores hidrofilicos para conjugados anticuerpo-farmaco.
|
|
CN112004557B
(zh)
|
2018-01-08 |
2024-07-30 |
里珍纳龙药品有限公司 |
类固醇类化合物及其抗体偶联物
|
|
CA3094313A1
(en)
|
2018-04-06 |
2019-10-10 |
Seattle Genetics, Inc. |
Camptothecin peptide conjugates
|
|
CN112533951A
(zh)
|
2018-05-09 |
2021-03-19 |
里珍纳龙药品有限公司 |
抗msr1抗体及其使用方法
|
|
MA53455B1
(fr)
|
2018-11-20 |
2022-11-30 |
Regeneron Pharma |
Dérivés de bis-octahydrophénanthrène carboxamide et leurs conjugués protéiques destinés à être utilisés en tant qu'agonistes de lxr
|
|
JP7591503B2
(ja)
|
2018-12-21 |
2024-11-28 |
リジェネロン ファーマシューティカルズ，インク． |
リファマイシンアナログおよびその抗体薬物コンジュゲート
|
|
US20230119539A1
(en)
|
2019-01-08 |
2023-04-20 |
Regeneron Pharmaceuticals, Inc. |
Traceless linkers and protein-conjugates thereof
|
|
EP3908323A2
(en)
|
2019-01-08 |
2021-11-17 |
Regeneron Pharmaceuticals, Inc. |
Traceless linkers and protein-conjugates thereof
|